Bio-Rad Laboratories – Consensus Indicates Potential 4.1% Upside

Broker Ratings

Bio-Rad Laboratories with ticker code (BIO) have now 5 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 930 and 795 calculating the mean target price we have 844.4. Given that the stocks previous close was at 810.79 this indicates there is a potential upside of 4.1%. The 50 day moving average now sits at 773.53 and the 200 moving average now moves to 649.3. The market capitalisation for the company is $24,558m. Company Website: http://www.bio-rad.com

Bio-Rad Laboratories develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories was founded in 1952 and is headquartered in Hercules, California.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits
You might also enjoy reading  Bio-Rad Laboratories - Consensus Indicates Potential 9.0% Upside

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index